
voriconazole iv brand names and other generic formulations include:
Vfend IV IV
cabozantinib oral brand names and other generic formulations include:
Cometriq Oral
voriconazole iv and cabozantinib oral
voriconazole iv will increase the level or effect of cabozantinib oral by altering drug metabolism. Avoid this combination; if you must take together, decrease cabozantinib dose by 40 mg/day; start taking the previous dose 2-3 days after the other drug is stopped.
voriconazole iv and cabozantinib oral
voriconazole iv will increase the level or effect of cabozantinib oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid coadministration of cabozantinib with strong CYP3A4 inhibitors. If a strong CYP3A4 inhibitor is required, decrease cabozantinib dose by 40 mg/day (Cometriq) or by 20 mg/day (Cabometyx). Resume previous dose 2-3 days after strong CYP3A4 inhibitor discontinued.
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant